These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20213666)

  • 21. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
    Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M;
    HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546
    [No Abstract]   [Full Text] [Related]  

  • 22. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
    Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
    Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
    Buzón MJ; Marfil S; Puertas MC; Garcia E; Clotet B; Ruiz L; Blanco J; Martinez-Picado J; Cabrera C
    Antivir Ther; 2008; 13(7):881-93. PubMed ID: 19043922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
    Palmisano L; Giuliano M; Galluzzo CM; Amici R; Andreotti M; Weimer LE; Pirillo MF; Fragola V; Bucciardini R; Vella S
    HIV Med; 2009 Sep; 10(8):477-81. PubMed ID: 19459989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.
    Cuzin L; Delpierre C; Gerard S; Massip P; Marchou B
    Clin Infect Dis; 2007 Sep; 45(5):654-7. PubMed ID: 17683004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    HIV Med; 2007 Mar; 8(2):80-5. PubMed ID: 17352763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid organ transplantation in HIV-infected recipients.
    El Sayegh S; Keller MJ; Huprikar S; Murphy B
    Pediatr Transplant; 2004 Jun; 8(3):214-21. PubMed ID: 15176956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
    Marcelin AG; Tubiana R; Lambert-Niclot S; Lefebvre G; Dominguez S; Bonmarchand M; Vauthier-Brouzes D; Marguet F; Mousset-Simeon N; Peytavin G; Poirot C
    AIDS; 2008 Aug; 22(13):1677-9. PubMed ID: 18670231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving clinical strategies for transplantation in the HIV-positive recipient.
    Stock PG; Roland ME
    Transplantation; 2007 Sep; 84(5):563-71. PubMed ID: 17876267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipients.
    Primeggia J; Timpone JG; Kumar PN
    Infect Dis Clin North Am; 2013 Jun; 27(2):473-86. PubMed ID: 23714350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
    Moanna A; Rimland D
    Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of an observational database to assess antiretroviral treatment trends in India.
    Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N
    Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
    Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
    Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful tacrolimus treatment following renal transplant in a HIV-infected patient with raltegravir previously treated with a protease inhibitor based regimen.
    Cousins D; Topping K; Lee V; Sweeney J; Lawton M
    Drug Metabol Drug Interact; 2011; 26(3):139-41. PubMed ID: 21980965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human immunodeficiency virus (HIV) type 1 with R5 tropism among HIV-1 antiretroviral-experienced patients in Spain].
    Arribas JR; Rivero A; Leal M; Sánchez-de la Rosa R
    Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):559-60. PubMed ID: 20400209
    [No Abstract]   [Full Text] [Related]  

  • 39. Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients.
    Cattaneo D; Ripamonti D; Gervasoni C; Landonio S; Meraviglia P; Baldelli S; Cozzi V; Fucile S; Clementi E
    J Clin Pharmacol; 2012 Mar; 52(3):440-5. PubMed ID: 21383337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent prurigo nodularis in HIV-infected patient responsive to antiretroviral therapy with raltegravir.
    Motegi S; Kato M; Uchiyama A; Yamada K; Shimizu A; Amano H; Ishikawa O
    J Dermatol; 2014 Mar; 41(3):272-3. PubMed ID: 24479440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.